107 related articles for article (PubMed ID: 3415779)
1. Enhanced brachial artery compliance following perindopril in essential hypertension.
Asmar RG; Safar ME; Santoni JP; Pannier BM; London GM
Am J Hypertens; 1988 Jul; 1(3 Pt 3):103S-105S. PubMed ID: 3415779
[TBL] [Abstract][Full Text] [Related]
2. Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension.
Asmar RG; Pannier B; Santoni JP; Laurent S; London GM; Levy BI; Safar ME
Circulation; 1988 Oct; 78(4):941-50. PubMed ID: 2971473
[TBL] [Abstract][Full Text] [Related]
3. Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension.
Asmar RG; Journo HJ; Lacolley PJ; Santoni JP; Billaud E; Levy BI; Safar ME
J Hypertens Suppl; 1988 Dec; 6(3):S33-9. PubMed ID: 3225688
[TBL] [Abstract][Full Text] [Related]
4. [Cardiac hypertrophy and arterial compliance after antihypertensive treatment].
Asmar RG; Pannier BM; London GM; Safar ME
Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():79-83. PubMed ID: 1838923
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic effects of perindopril in essential hypertension.
Asmar RG; Pannier B; Laurent ST; Benetos A; Daou J; Safar M
J Hum Hypertens; 1990 Oct; 4 Suppl 4():35-43; discussion 44. PubMed ID: 2283652
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme inhibition, pulse wave velocity and ambulatory blood pressure measurements in essential hypertension.
Santoni JP; Asmar R; Safar ME
Clin Exp Hypertens A; 1989; 11 Suppl 2():535-44. PubMed ID: 2691127
[TBL] [Abstract][Full Text] [Related]
7. Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives.
Tropeano AI; Boutouyrie P; Pannier B; Joannides R; Balkestein E; Katsahian S; Laloux B; Thuillez C; Struijker-Boudier H; Laurent S
Hypertension; 2006 Jul; 48(1):80-6. PubMed ID: 16702490
[TBL] [Abstract][Full Text] [Related]
8. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
Forette F; McClaran J; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
Clin Exp Hypertens A; 1989; 11 Suppl 2():587-603. PubMed ID: 2691131
[TBL] [Abstract][Full Text] [Related]
9. Perindopril, converting enzyme blockade, and peripheral arterial hemodynamics in the healthy volunteer.
Richer C; Thuillez C; Giudicelli JF
J Cardiovasc Pharmacol; 1987 Jan; 9(1):94-102. PubMed ID: 2434802
[TBL] [Abstract][Full Text] [Related]
10. Vascular effects of perindopril: from experimental to clinical investigation.
Scalbert E; Levy B; Desche P; Devissaguet M; Safar ME
J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S25-32. PubMed ID: 1725197
[TBL] [Abstract][Full Text] [Related]
11. ACE inhibition and brachial artery haemodynamics in hypertension.
Simon AC; Levenson JA; Safar AM; Bouthier JD; Safar ME
Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):243S-247S. PubMed ID: 6099739
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of effects of angiotensin converting enzyme inhibitor perindopril on function of endothelium of arterial vessels in patients with ischemic heart disease and hypertension].
Kirichenko LL; Iarygina MA; Korolev AP; Masenko VP; Tseka OS; Rusak TV; Panchenkova EA
Kardiologiia; 2004; 44(10):54-6. PubMed ID: 15477791
[No Abstract] [Full Text] [Related]
13. Cardiac hypertrophy and arterial compliance following drug treatment in hypertension.
Asmar RG; Pannier BM; London GM; Safar ME
J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S37-9. PubMed ID: 1725199
[TBL] [Abstract][Full Text] [Related]
14. Peripheral haemodynamic effects of perindopril compared in patients with congestive heart failure and in normal volunteers.
Thuillez C; Richard C; Richer C; Loueslati H; Perret L; Auzépy P; Giudicelli JF
J Hypertens Suppl; 1988 Dec; 6(3):S41-3. PubMed ID: 2852235
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin converting enzyme inhibition decreases systolic blood pressure more than diastolic pressure as shown by ambulatory blood pressure monitoring.
Asmar RG; Pannier BM; Santoni JP; Safar ME
J Hypertens Suppl; 1988 Dec; 6(3):S79-81. PubMed ID: 3225692
[TBL] [Abstract][Full Text] [Related]
16. Effects of ACE inhibitor therapy on derived central arterial waveforms in hypertension.
Dart AM; Reid CM; McGrath B;
Am J Hypertens; 2001 Aug; 14(8 Pt 1):804-10. PubMed ID: 11497198
[TBL] [Abstract][Full Text] [Related]
17. Effects of perindopril on ambulatory intra-arterial blood pressure, cardiovascular reflexes and forearm blood flow in essential hypertension.
West JN; Smith SA; Stallard TJ; Littler WA
J Hypertens; 1989 Feb; 7(2):97-104. PubMed ID: 2647846
[TBL] [Abstract][Full Text] [Related]
18. Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke.
Dyker AG; Grosset DG; Lees K
Stroke; 1997 Mar; 28(3):580-3. PubMed ID: 9056614
[TBL] [Abstract][Full Text] [Related]
19. Large and small artery endothelial function in patients with essential hypertension--effect of ACE inhibition and beta-blockade.
Buus NH; Jørgensen CG; Mulvany MJ; Sørensen KE
Blood Press; 2007; 16(2):106-13. PubMed ID: 17612909
[TBL] [Abstract][Full Text] [Related]
20. Humoral effects of perindopril in essential hypertension.
Sagnella GA; Markandu ND; Singer DR; Buckley MG; Miller MA; MacGregor GA
Eur J Clin Pharmacol; 1991; 41(6):625-6. PubMed ID: 1815981
[No Abstract] [Full Text] [Related]
[Next] [New Search]
